Meanwhile, Patent Land...

[Anonymous]

NEW YORK (TheStreet) -- Eli Lilly (LLY - Get Report) shares are down 1.87% to $69.27 in early market trading on Friday after a German court ruled against it in a patent case involving its Alimta lung cancer drug.

The court ruled that generic drug maker Actavis (ACT) would not infringe on the company's patent by marketing an alternative salt form of the Alimta, known as pemetrexed, once the drug's compound patent expires at the end of this year.


AND...

A California federal judge declined to invalidate two Genentech Inc. patents covering biotechnology used to make drugs for cancer and autoimmune diseases, ruling Thursday that Eli Lilly and Co.’s arguments that the method was double-patented were unpersuasive.

Lilly sought summary judgment of invalidity for the two patents, called Cabilly II and Cabilly III, held by Genentech and nonprofit City of Hope, claiming the patents were invalid under the doctrine of obviousness-type double-patenting.

The judge found Ellie Silly's assertions utterly ridiculous. So way to go on to back-to-back court losses. Let the "reallocations" accelerate!

 

[Anonymous]

NEW YORK (TheStreet) -- Eli Lilly (LLY - Get Report) shares are down 1.87% to $69.27 in early market trading on Friday after a German court ruled against it in a patent case involving its Alimta lung cancer drug.

The court ruled that generic drug maker Actavis (ACT) would not infringe on the company's patent by marketing an alternative salt form of the Alimta, known as pemetrexed, once the drug's compound patent expires at the end of this year.


AND...

A California federal judge declined to invalidate two Genentech Inc. patents covering biotechnology used to make drugs for cancer and autoimmune diseases, ruling Thursday that Eli Lilly and Co.’s arguments that the method was double-patented were unpersuasive.

Lilly sought summary judgment of invalidity for the two patents, called Cabilly II and Cabilly III, held by Genentech and nonprofit City of Hope, claiming the patents were invalid under the doctrine of obviousness-type double-patenting.

The judge found Ellie Silly's assertions utterly ridiculous. So way to go on to back-to-back court losses. Let the "reallocations" accelerate!

Let's face it, Lilly is HORRIBLE when it comes to patent protection, formulary coverage, and first in class/best in class!!! Lilly has been on path of disaster since 2004 and can't seem to shake it!

 

[Anonymous]

Thanks to the AIA a new, amazing feature called IPR allows a third party to take out almost any patent for pennies on the dollar compared to litigation. Legions of wrongly terminated scientists will point out the vulnerabilities, with glee. Enjoy your limited time as a going concern.

 

[Anonymous]

Thanks to the AIA a new, amazing feature called IPR allows a third party to take out almost any patent for pennies on the dollar compared to litigation. Legions of wrongly terminated scientists will point out the vulnerabilities, with glee. Enjoy your limited time as a going concern.

Take out = invalidate; >70% success rate for the petitioners thus far; look it up.

 

[Anonymous]

What do you propose we do to correct this?

 

[Anonymous]

What do you propose we do to correct this?

Give up on the illusion of "drug discovery" @ lly. Become reverse patent trolls. Collect "tributes" for not initiating an IPR with the USPTO which has a >70% chance of invalidating the challenged patent. Then move onto the next, and the next and the next...anyone can (and should) do it.

 

[Anonymous]

What do you propose we do to correct this?

Use the soccer field for Indy 11 games, open the Reveli pub to the public, and rent the corporate jets out for tours over Indy. You need to think outside the box. Lilly doesn't have what it takes to be a big pharma leader anymore.

 

[Anonymous]

Great ideas. There is hope.

 

[Anonymous]

Use the soccer field for Indy 11 games, open the Reveli pub to the public, and rent the corporate jets out for tours over Indy. You need to think outside the box. Lilly doesn't have what it takes to be a big pharma leader anymore.

Soccer-- with extreme prejudice. The MVP chosen by our own Jonnie Snow then rules Marion County for the next year. IN is essentially a real world Hunger Games (only w. Type 2 diabetes).